Archived Facts

Posts Tagged ‘lung’

Washington, DC (PRWEB) July 01, 2014

Blue Water was recently recognized by the Web Marketing Associations 12th annual Internet Advertising Competition (IAC) for the American Lung Associations Share Your Story campaign. Named Best Associations Integrated Ad Campaign and Best Health Care Integrated Ad Campaign, the campaign honored Lung Cancer Awareness Month and provided support to patients, caregivers and survivors whose lives have been impacted by the disease.

The Share Your Story campaign is part of the American Lung Associations Facing Lung Cancer microsite, http://www.mylungcancersupport.org, which provides resources and education to individuals and families living with a lung cancer diagnosis. By facilitating public discussion around lung cancer, the #1 cancer killer of men and women in the United States, the Share Your Story campaign continues to help build awareness and reduce stigma around the disease, offering a source of support and providing a sense of reassurance and inspiration to those facing lung cancer.

The campaign consisted of a revamped homepage mosaic showcasing real people’s lung cancer stories and photos, landing pages where people could submit their stories and read those of others, buttons to facilitate social media sharing, and a tab to gather stories from Facebook. Additionally, a press release, e-newsletter, Facebook posts and Tweets (using the hashtag #LCAM) were sent out to encourage story submissions and honor the stories shared. As a result of this campaign, visits to the website in the month of November increased by 102 percent from the previous month, with a total of 130 stories shared.

About the Internet Advertising Competition

Produced by the Web Marketing Association, the Internet Advertising Competition honors excellence in online advertising, recognizes the individuals and organizations responsible, and showcases the best in Internet advertising. First conducted in 1999, it is the first and only competition dedicated exclusively to online advertising.

The IACs 2014 judges represent some of the greatest minds and leaders within the Internet Advertising community, including: Arc Worldwide, BGT Partners, Brunner Digital, Campbell-Ewald, CNN News Group, Deep Interactive Asia, Digitas, EuroRSCG 4D, Google, IBM Interactive, imc2, JWT, LeapFrog Interactive, Mass Transmit, McCann Worldgroup, Razorfish, Starwood Hotels & Resorts, Tectis GmbH, TMP Worldwide, Universal McCann Interactive and Wunderman / Y&R. These judges evaluate websites based on creativity, innovation, impact, design, copywriting, memorability, and use of the medium.

About Blue Water

Blue Water is an award-winning information technology, web design, and interactive marketing agency based in Washington, D.C., with offices in New York and San Francisco. The firm provides Government, business, and non-profit clients with full lifecycle support for digital initiatives including custom web & software development, commercial and government website design, digital marketing, hosting, 508 compliance and ongoing site maintenance. Leveraging cutting edge web design techniques, flexible open source software applications, emerging technologies, and integrated marketing campaigns, Blue Water Media offers a turnkey approach to attaining online success. For more information, please visit: http://www.bwm.com/.







Related Posts:

A woman whose son died of cystic fibrosis in 2009 successfully sued on Thursday to get his younger brother, now 11, on the adult waiting list for a lung transplant.A woman whose son died of cystic fibrosis in 2009 successfully sued on Thursday to get his younger brother, now 11, on the adult waiting list for a lung transplant.


Related Posts:

(Reuters) – Lung cancer rates have been falling across the United States over the past decade, but deaths from the disease are steady or rising among middle-aged women in the South and Midwest, according to a study based on more than one million women.

Incoming search terms:

Related Posts:

Wilmington, NC (PRWEB) January 07, 2012

AccuGenomics announced today that it will be attending the upcoming OneMedForum at the Sir Francis Drake hotel in San Francisco on January 9-12, coinciding with the JP Morgan Global Healthcare Conference. AccuGenomics, founded in 2010, develops and commercializes standardized gene expression tests that accurately diagnose, monitor and guide cancer treatment. Capitalizing on a high growth diagnostic market, the company offers highly differentiated solutions in molecular diagnostics for leukemia and lung cancer.

Standardization sets AccuGenomics apart in gene expression testing. The companys standardized nucleic acid quantification (SNAQ) method streamlines complex molecular diagnostic testing that meets FDA guidelines and facilitates rapid deployment in a variety of laboratory settings. SNAQ allows hundreds of robust qPCR measurements from limited patient samples. It is insensitive to the variations of instruments, laboratories and sample quality. SNAQ technology also enables bench top complex molecular testing of limited and degraded samples. Thus AccuGenomics quantitative, reproducible and accurate numerical gene expression measurements are unparalleled.

During 2012, AccuGenomics will be pursuing FDA approval for its standardized test for Chronic Myeoloid Leukemia (CML) treatment monitoring, in collaboration with Cancer Genetics, Inc. (CGI), a leader in the personalization of cancer treatment. CGI will offer the test in their CLIA lab as a CLIA approved test in early 2012. It accurately monitors treatment efficiency in CML patients previous diagnosed with a BCR-ABL fusion gene event. CML is not currently curable but can be controlled with established conventional drug therapies in most patients. Accurate measurements of BCR-ABL fusion transcript are critical to managing CML in those patients who have advanced to accelerated and blast phases as a result of poor response to treatment.

The field of molecular diagnostics has been seeking a broadly applicable method of standardization to facilitate comparability of data across all labs and platforms, said Dr. Nick Lazaridis, President of AccuGenomics. Our leading-edge diagnostic solutions in oncology fill that need. We look forward to making new strides in gene expression testing in 2012.

About AccuGenomics

AccuGenomics is a diagnostic company focused on developing standardized molecular diagnostic tests in oncology utilizing its patented technology. These gene expression tests will generate disease specific data that provide accuracy and intrinsic quality control for patient solutions. Additional information: http://www.accugenomics.com.

###





Incoming search terms:

Related Posts:

NEW YORK (Reuters Life!) – CT scans to measure lung tumors can be unreliable, potentially leading patients and doctors to believe cancer is growing when it’s not, according to a study.

Related Posts:

A much-anticipated drug for advanced lung cancer from Pfizer Inc. appears to double survival over standard drugs against tumors with a certain genetic mutation, according to research presented Sunday.

Related Posts:

Scientists have identified a key enzyme responsible for destroying lung tissue in tuberculosis (TB) and say the finding could lead swiftly to new treatments for the highly infectious disease.

Related Posts:

Working with Tunstall Healthcare’s new ICP (integrated care platform), the first deployment in London, the system enables patients with conditions such as heart failure or lung disease, to make a range of checks appropriate to them, …

Go here to see the original:
Revolutionary System for Healthcare in Patients' Homes

Related Posts:

Study Finds People Living With Lung Cancer Are too Often Stigmatized Because of Link to Smoking
WASHINGTON, July 13 /PRNewswire-USNewswire/ — Today, Lung Cancer Alliance (LCA) highlighted a study, carried out by Ipsos MORI on behalf of The Global Lung Cancer Coalition (GLCC). The study finds lung cancer patients are likely to suffer significant stigma due to the disease’s link to smoking. Over 16,000 people in 16 countries were asked questions about their attitudes surrounding lung cancer …

Read more on redOrbit

Related Posts:

Regenerated Lung Tissue Implanted In Rats
A Yale University-led team of scientists reports that it has achieved an important first step in regenerating fully functional lung tissue that can exchange gas, which is the key role of the lungs. Their paper appears in Science Express. Lung disease accounts for around 400,000 deaths each year in the United States. Lung tissue is difficult to regenerate because it does not generally repair or …

Read more on Medical News Today

Incoming search terms:

Related Posts: